These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3880587)

  • 21. The ethics of human gene therapy.
    Walters L
    Nature; 1986 Mar 20-26; 320(6059):225-7. PubMed ID: 3457268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical issues in human gene therapy.
    Walters L
    J Clin Ethics; 1991; 2(4):267-74; discussion 274-8. PubMed ID: 1804397
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy and genetic alteration.
    Hum Gene Ther; 1994 May; 5(5):603-14. PubMed ID: 8054376
    [No Abstract]   [Full Text] [Related]  

  • 24. Human gene therapy: ethics and public policy.
    Walters L
    Hum Gene Ther; 1991; 2(2):115-22. PubMed ID: 1911932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overregulation is an unnecessary hindrance to human gene therapy.
    Miller HI
    Hum Gene Ther; 1995 Nov; 6(11):1361-2. PubMed ID: 8573609
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene therapy: US clinical trials imminent.
    Budiansky S
    Nature; 1984 Nov 29-Dec 5; 312(5993):393. PubMed ID: 6594577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 28. The revised "Points to Consider" document.
    Hum Gene Ther; 1990; 1(1):93-103. PubMed ID: 2081190
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical considerations in the design of protocols for somatic gene therapy.
    Ledley FD
    Hum Gene Ther; 1991; 2(1):77-83. PubMed ID: 1863643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Points to consider in the design and submission of human somatic cell gene therapy protocols.
    Recomb DNA Tech Bull; 1985 Dec; 8(4):181-6. PubMed ID: 3912845
    [No Abstract]   [Full Text] [Related]  

  • 31. Hasty compassion.
    Lancet; 1993 Mar; 341(8846):663. PubMed ID: 8095574
    [No Abstract]   [Full Text] [Related]  

  • 32. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Human Gene Therapy Subcommittee. Minutes of meeting, December 9, 1988.
    Recomb DNA Tech Bull; 1989 Mar; 12(1):29-45. PubMed ID: 2657876
    [No Abstract]   [Full Text] [Related]  

  • 33. Human gene therapy: a biopolitical overview and analysis.
    Carmen IH
    Hum Gene Ther; 1993 Apr; 4(2):187-93. PubMed ID: 8494928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a points to consider document for human somatic cell gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1985 Dec; 8(4):176-80. PubMed ID: 3867980
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulatory concerns in human gene therapy.
    Epstein SL
    Hum Gene Ther; 1991; 2(3):243-9. PubMed ID: 1751592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discussions on human gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1986 Jun; 9(2):88-130. PubMed ID: 3532218
    [No Abstract]   [Full Text] [Related]  

  • 37. Human fetal gene therapy: moral and ethical questions.
    Fletcher JC; Richter G
    Hum Gene Ther; 1996 Aug; 7(13):1605-14. PubMed ID: 8864761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panel that reviews gene tests in humans has no applications.
    Weiss R
    Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
    [No Abstract]   [Full Text] [Related]  

  • 39. TNF/TIL human gene therapy clinical protocol.
    Hum Gene Ther; 1990; 1(4):441-80. PubMed ID: 2078586
    [No Abstract]   [Full Text] [Related]  

  • 40. RAC approves accelerated review!
    Anderson WF
    Hum Gene Ther; 1994 Jun; 5(6):665-6. PubMed ID: 7948128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.